SetPoint Medical Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
90
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$115M
- Investors
-
29
SetPoint Medical General Information
Description
Developer of an implantable bioelectronic medical device designed to modulate neuroimmune pathways for reducing inflammation and restoring immunologic balance in chronic autoimmune conditions. The company delivers targeted electrical stimulation to the vagus nerve through a small, wireless implant programmed to provide daily therapy automatically with low maintenance, enabling healthcare providers and patients managing autoimmune diseases such as rheumatoid arthritis to access an alternative to traditional drug treatments with potentially reduced risk and treatment burden.
Contact Information
Website
www.setpointmedical.comCorporate Office
- 25101 Rye Canyon Loop
- Valencia, CA 91355
- United States
Corporate Office
- 25101 Rye Canyon Loop
- Valencia, CA 91355
- United States
SetPoint Medical Timeline
SetPoint Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 16. Later Stage VC (Series D) | 28-Oct-2025 | $115M | Completed | Generating Revenue | ||
| 15. General Corporate Purpose | 19-Jan-2023 | Completed | Clinical Trials - Phase 2 | |||
| 14. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 13. Later Stage VC (Series C) | 13-Jan-2023 | Completed | Clinical Trials - Phase 2 | |||
| 12. Secondary Transaction - Private | 01-Jan-2023 | Completed | Clinical Trials - Phase 2 | |||
| 11. Mezzanine | 29-Dec-2022 | Completed | Clinical Trials - General | |||
| 10. Mezzanine | 29-Jun-2021 | Completed | Clinical Trials - General | |||
| 9. Later Stage VC (Series B) | 09-Nov-2020 | Completed | Clinical Trials - General | |||
| 8. Debt - PPP | 13-Apr-2020 | $1.1M | $106M | Completed | Clinical Trials - General | |
| 7. Later Stage VC (Series A) | 17-Sep-2019 | $15.7M | $106M | Completed | Clinical Trials - General |
SetPoint Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | 65,407,963 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 20.55% |
| Series A | 42,604,328 | $0.001000 | 8% | $1 | $1 | 1x | $1 | 13.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
SetPoint Medical Comparisons
Industry
Financing
Details
SetPoint Medical Competitors (13)
One of SetPoint Medical’s 13 competitors is Salvia BioElectronics, a Venture Capital-Backed company based in Eindhoven, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Salvia BioElectronics | Venture Capital-Backed | Eindhoven, Netherlands | ||||
| Mainstay Medical | Venture Capital-Backed | San Diego, CA | ||||
| Saluda Medical | Formerly PE-Backed | Bloomington, MN | ||||
| Aleva Neurotherapeutics | Private Equity-Backed | Lausanne, Switzerland | ||||
| Curonix | Private Equity-Backed | Pompano Beach, FL |
SetPoint Medical Patents
SetPoint Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260124450-A1 | Methods for treating bone erosion | Pending | 01-Nov-2024 | ||
| WO-2026073166-A1 | Treatment of senescence by vagus nerve stimulation | Pending | 27-Sep-2024 | ||
| US-20240307688-A1 | Bimodal vagus nerve stimulation to treat neurodegenerative disorders | Pending | 14-Mar-2023 | ||
| EP-4655868-A2 | Radio frequency power management and optimization | Pending | 25-Jan-2023 | ||
| WO-2024158948-A2 | Radio frequency power management and optimization | Inactive | 25-Jan-2023 | G01R31/2822 |
SetPoint Medical Signals
SetPoint Medical Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abbott | Corporation | Minority | ||
| Ally Bridge Group | Growth/Expansion | Minority | ||
| Elevage Medical Technologies | Growth/Expansion | Minority | ||
| Northwell Health | Corporation | Minority | ||
| SPRIG Equity | Venture Capital | Minority |
SetPoint Medical FAQs
-
When was SetPoint Medical founded?
SetPoint Medical was founded in 2007.
-
Where is SetPoint Medical headquartered?
SetPoint Medical is headquartered in Valencia, CA.
-
What is the size of SetPoint Medical?
SetPoint Medical has 90 total employees.
-
What industry is SetPoint Medical in?
SetPoint Medical’s primary industry is Therapeutic Devices.
-
Is SetPoint Medical a private or public company?
SetPoint Medical is a Private company.
-
What is the current valuation of SetPoint Medical?
The current valuation of SetPoint Medical is .
-
What is SetPoint Medical’s current revenue?
The current revenue for SetPoint Medical is .
-
How much funding has SetPoint Medical raised over time?
SetPoint Medical has raised $581M.
-
Who are SetPoint Medical’s investors?
Abbott, Ally Bridge Group, Elevage Medical Technologies, Northwell Health, and SPRIG Equity are 5 of 29 investors who have invested in SetPoint Medical.
-
Who are SetPoint Medical’s competitors?
Salvia BioElectronics, Mainstay Medical, Saluda Medical, Aleva Neurotherapeutics, and Curonix are some of the 13 competitors of SetPoint Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process